Results 11 to 20 of about 9,486 (169)
Paraoxonase 1 Phenotype and Paraoxonase Activity in Asthmatic Patients
Iranian Journal of Allergy, Asthma and Immunology, 2015 Oxidative stress is involved in the pathogenesis of asthma. Paraoxonase 1 (PON1) and arylesterase are esterase enzymes displaying antioxidant characteristics.
Nurhan Sarioglu +4 more
doaj +5 more sources
Misconceptions about paraoxonase-1
Brazilian Journal of Otorhinolaryngology, 2022 Michael Mackness, Eser Y. Sozmen
doaj +4 more sources
Paraoxonase 1 Activity and Survival in Sepsis Patients
Balkan Medical Journal, 2015 Background: Sepsis is a state of augmented oxidative stress and diminished antioxidant capacity. High density lipoprotein (HDL) particles were shown to possess antioxidant and anti-inflammatory properties, as well as Paraoxonase 1 (PON1), which is an ...
Volkan İnal +4 more
doaj +6 more sources
Genetic polymorphisms of paraoxonase 1 and susceptibility to atherogenesis [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2013 Introduction. Paraoxonase 1 (PON1) is a multifunctional enzyme associated with high-density lipoprotein particles (HDL). It is a cellular antioxidant that hydrolyses oxidized macromolecules, especially low-density lipoproteins (ox-LDL).
Grubiša Ivana +5 more
doaj +4 more sources
Paraoxonase-1 and clopidogrel efficacy [PDF]
Nature Medicine, 2011 Clopidogrel active thiol metabolite is formed through 1) a cytochrome P450 (CYP dependent oxidation to a thiolactone : 2-oxoclopidogrel. Then a second CYP dependent oxidation to a sulfenic acid which is reduced by excess glutathione to the active cis -thiol-acid.
Thomas, Cuisset +5 more
+10 more sources
Paraoxonase 1 polymorphisms and survival [PDF]
European Journal of Human Genetics, 2004 The antioxidant enzyme paraoxonase 1 (PON1) has previously been suggested to confer protection against coronary heart disease (CHD), one of the main causes of death in the Western world. Two coding polymorphisms, 55M/L and 192Q/R, and a promoter variant, -107C/T, has been extensively studied with respect to susceptibility to CHD. In this study, we have
Christiansen, Lene +3 more
openaire +2 more sources
Paraoxonase 1 in neurological disorders [PDF]
Redox Report, 2013 Paroxonase 1 displays multiple physiological activities that position it as a putative player in the pathogenesis of neurological disorders. Here we reviewed the literature focusing on the role of paraoxonase 1 (PON1) as a factor in the risk of stroke and the major neurodegenerative diseases.
Teresita, Menini, Alejandro, Gugliucci
openaire +2 more sources
The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3 [PDF]
Molecules, 2020 Serum paraoxonase-1 (PON1) is the most studied member of the group of paraoxonases (PONs). This enzyme possesses three enzymatic activities: lactonase, arylesterase, and paraoxonase activity. PON1 and its isoforms play an important role in drug metabolism as well as in the prevention of cardiovascular and neurodegenerative diseases.
Ajda Taler-Verčič +2 more
openaire +4 more sources
Solubilization and Humanization of Paraoxonase-1 [PDF]
Journal of Lipids, 2012 Paraoxonase-1 (PON1) is a serum protein, the activity of which is related to susceptibility to cardiovascular disease and intoxication by organophosphorus (OP) compounds. It may also be involved in innate immunity, and it is a possible lead molecule in the development of a catalytic bioscavenger of OP pesticides and nerve agents.
Mohosin Sarkar +8 more
openaire +2 more sources
Paraoxonase 1 status in the Thai population [PDF]
Journal of Human Genetics, 2005 Human serum paraoxonase 1 (PON1), a high-density lipoprotein (HDL)-associated enzyme, has been shown to reduce the oxidation of low-density lipoprotein (LDL) and HDL by degrading lipid peroxides. This property of PON1 accounts for its ability to protect against atherosclerosis.
Wimon, Phuntuwate +4 more
openaire +2 more sources